Staphysagria (BrandStorm HBC)
Welcome to the PulseAid listing for the Staphysagria drug offered from BrandStorm HBC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | BrandStorm HBC |
NON-PROPRIETARY NAME: | DELPHINIUM STAPHISAGRIA SEED |
SUBSTANCE NAME: | DELPHINIUM STAPHISAGRIA SEED |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | SUBLINGUAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2011-11-30 |
END MARKETING DATE: | 2019-07-22 |
Staphysagria HUMAN OTC DRUG Details:
Item Description | Staphysagria from BrandStorm HBC |
LABELER NAME: | BrandStorm HBC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30([hp_C]/1) |
START MARKETING DATE: | 2011-11-30 |
END MARKETING DATE: | 2019-07-22 |
PRODUCT ID: | 76472-1164_689a08d8-aff4-4a49-be69-c677bf57bd0c |
PRODUCT NDC: | 76472-1164 |
APPLICATION NUMBER: | |
Other DELPHINIUM STAPHISAGRIA SEED Pharmaceutical Manufacturers / Labelers: